Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 412

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

Open access
Bauer, Daniel E., Mitchell, Chelsey M., Strait, Kelly M., Lathan, Christopher S., Stelow, Edward B., Lüer, Sonja C., Muhammed, Somala, Evans, Andrew G., Sholl, Lynette M., Rosai, Juan, Giraldi, Eugenia, Oakley, Richard P., Rodriguez-Galindo, Carlos, London, Wendy B., Sallan, Stephen E., Bradner, James E., French, Christopher A. · 2012 · Clinical Cancer Research

Abstract

Purpose: NUT midline carcinoma (NMC) is a poorly differentiated squamous cancer characterized by rearrangement of the NUT gene. Research advances have provided opportunities for targeted therapy in NMC, yet the clinical features of this rare disease have not been systematically characterized. We report on a large population of such patients to identify the disease characteristics and treatments, correlate them with outcome, and to consider clinical recommendations. Experimental Design: A clinical database was established using retrospective demographic and outcomes data available on all known cases of NMC. Questionnaires were completed by treating physicians. Pathologic, demographic, and clinical variables were assessed for 63 patients, the largest cohort of patients with NMC studied to date. Outcome data from 54 patients were available for survival analyses. Results: The diagnosis of NMC has increased annually since 2007. Since 2009, there has been an observed increase in the age at diagnosis (P < 0.05). Geographic distribution of patients with NMC has been concentrated in the United States (n = 41, 65%). The median overall survival for patients with NMC was 6.7 months. The 2-year progression-free survival (PFS) was 9% with a 95% confidence interval (CI) of 1% to 17% [1-year PFS 15% (5–24%) and 2-year overall survival (OS) was 19% with a 95% CI of 7%–31% (1-year OS: 30% (27–34%)]. Multivariate analysis suggested that extent of surgical resection and initial radiotherapy were independent predictors of PFS and OS. Notably, no chemotherapeutic regimen was associated with improved outcome. Conclusions: NMC portends a poor prognosis among all squamous cell neoplasms and seems to be frequently unrecognized. The finding that conventional chemotherapy has been inadequate indicates a pressing need for the development of targeted therapeutics. Intensive local therapies such as gross total resection and radiotherapy might be associated with enhanced survival. Clin Cancer Res; 18(20); 5773–9. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-12-1153

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 412

Metadata

Authors
Bauer, D. E., Mitchell, C. M., Strait, K. M., Lathan, C. S., Stelow, E. B., Lüer, S. C., Muhammed, S., Evans, A. G., Sholl, L. M., Rosai, J., Giraldi, E., Oakley, R. P., Rodriguez-Galindo, C., London, W. B., Sallan, S. E., Bradner, J. E., & French, C. A.
Venue
Clinical Cancer Research
Published
2012-10-14
Volume
18
Issue
20
Pages
5773-5779
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2144858115
Cited by
412
References
9
FWCI
16.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-12-1153
The paper
Bauer, D. E., Mitchell, C. M., Strait, K. M., Lathan, C. S., Stelow, E. B., Lüer, S. C., Muhammed, S., Evans, A. G., Sholl, L. M., Rosai, J., Giraldi, E., Oakley, R. P., Rodriguez-Galindo, C., London, W. B., Sallan, S. E., Bradner, J. E., & French, C. A. (2012). Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-12-1153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.